
David Schwartz
Deputy Editor at Newsday
Deputy editor at @Newsday. Formerly investigations, environment, politics. https://t.co/oU5iuSdGen
Articles
-
1 week ago |
businesswire.com | David Schwartz
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group announces that it is investigating claims on behalf of investors of Dyne Therapeutics (“Dyne” or “the Company”) (NASDAQ: DYN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
-
4 weeks ago |
thompsonhinesmartrade.com | David Schwartz |Francesca M.S. Guerrero |Michelle Li |Samir D. Varma
On May 29, 2025, the U.S. District Court for the District of Columbia (USDC-DC) issued a preliminary injunction ruling staying the imposition of President Donald Trump’s use of the International Emergency Economic Powers Act (IEEPA). This preliminary injunction applies to tariffs that would be paid by the two named plaintiffs – Learning Resources, Inc. and hand2mind, Inc.
-
1 month ago |
businesswire.com | David Schwartz
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group reminds investors of a class action lawsuit against Krispy Kreme, Inc. (“Krispy Kreme” or “the Company”) (NASDAQ: DNUT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DNUT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
-
1 month ago |
businesswire.com | David Schwartz
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group announces that it is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. (“Iovance” or “the Company”) (NASDAQ: IOVA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. Iovance released its financial results for the first quarter of 2025 on May 8, 2025.
-
1 month ago |
businesswire.com | David Schwartz
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group announces that it is investigating claims on behalf of investors of Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 7K
- DMs Open
- No

RT @ShariEinhorn: DANGEROUS ROADS: Fatal drugged driving crashes up on LI as lawmakers push to toughen law. The proportion of drivers who r…

RT @pitaarji: Proud to be part of this project, covering the human toll of driving on Long Island. 2,100+ killed, 16,000+ seriously injure…

RT @DavidOlson11: First measles case this year in Suffolk reported. The child, described as younger than 5, is hospitalized -- a reminder t…